Chronic Kidney Disease, Hyperkalemia and Echocardiographic Changes

Sponsor
Saglik Bilimleri Universitesi
Study ID
NCT06635590
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Patients with CKD ( eGFR \< \<60 mL/min/1,73 m2) presenting to emergency department with isolated hyperkalemia will be study population. Pre and post treatment ECG and echocardiographic findings will be recorded. Investigator will not intervene with the treatment decision of responsible physician and will not delay any intervetion or treatment for the sake of study. Data will be compared in terms of ECHO and ECG findings depending on hyperkalemia level and response to treatment.

Key Dates

Start date
Feb 1, 2024
Status verified
Oct 2024
Primary completion
Feb 1, 2025
Completion
Feb 1, 2025

Study Design

Enrollment
40 participants (estimated)

Arms

  • Arm: Hyperkalemia
    Study is planned as only 1 group of patient with hyperkalemia. Pre and post treatment data obtained from patients via ECG, ECHO and laboratory values will be recorded and evaluated in terms of literature. Patient-based findings will also be recorded and evaluated.

Primary Outcome Measure

ECHO changes [ Time Frame: from enrollment to the end of follow up duration of 30 days ]

Central Contacts

Related Studies